EyePoint Pharmaceuticals Inc. buy Cantor Fitzgerald
Start price
20.06.24
/
50%
€7.48
Target price
20.06.25
-
Performance (%)
-6.79%
End price
21.06.25
€6.98
Summary
This prediction ended on 21.06.25 with a price of €6.98. With a performance of -6.79%, the BUY prediction for EyePoint Pharmaceuticals Inc. by Cantor_Fitzgerald closed slightly in the red. Cantor_Fitzgerald has a follow-up prediction for EyePoint Pharmaceuticals Inc. where he still thinks EyePoint Pharmaceuticals Inc. is a Buy. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| EyePoint Pharmaceuticals Inc. | 5.310% | 5.310% | 45.157% |
| iShares Core DAX® | -0,22 % | 1,75 % | 2,66 % |
| iShares Nasdaq 100 | -2,35 % | 0,22 % | 32,49 % |
| iShares Nikkei 225® | -3,10 % | 2,93 % | 56,98 % |
| iShares S&P 500 | -0,50 % | 1,99 % | 24,47 % |
Comments by Cantor_Fitzgerald for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for EYPT provided by MarketBeat
In the thread Trading EyePoint Pharmaceuticals Inc.
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Current prediction by Cantor_Fitzgerald for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€12.20
08.07.26
08.07.26
€41.17
08.07.27
08.07.27
6.56%
09.07.26
09.07.26
Stopped prediction by Cantor_Fitzgerald for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.20
14.09.23
14.09.23
€29.02
14.09.24
14.09.24
-18.55%
15.09.24
15.09.24
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.00
31.08.23
31.08.23
€28.59
31.08.24
31.08.24
-13.24%
01.09.24
01.09.24